Group One Trading’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Group One Trading’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-40,000	Closed	-$25K	–	5835
2018 Q4	$25K	Sell	40,000 -36,200	-48%	-$37.6K	﹤0.01%	3938
2018 Q3	$99K	Hold	76,200	–	–	﹤0.01%	3547
2018 Q2	$103K	Buy	76,200 +7,600	+11%	+$11.6K	﹤0.01%	3545
2018 Q1	$99K	Buy	68,600 +4,300	+7%	+$8.98K	﹤0.01%	3255
2017 Q4	$145K	Buy	64,300 +20,000	+45%	+$50.6K	﹤0.01%	3135
2017 Q3	$151K	Buy	44,300 +23,100	+109%	+$77.7K	﹤0.01%	2965
2017 Q2	$75K	Buy	+21,200	New	+$69.8K	﹤0.01%	3291
2015 Q4	–	Sell	-500	Closed	-$2K	–	5629
2015 Q3	$2K	Hold	500	–	–	﹤0.01%	4733
2015 Q2	$2K	Buy	+500	New	+$4.79K	﹤0.01%	4723

Group One Trading's AST Position: Q4 2018 in Review

Group One Trading sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2018, closing a stake of 67,922 shares — an estimated $70.5K sold.

Group One Trading first reported a position in AST in Q4 2014 and held it in 14 quarters. The position peaked at $114K in Q3 2017. 46 funds tracked by Wall St. Rank hold AST as of Q4 2018.

Group One Trading reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2018 after selling out during the quarter.
Group One Trading sold 67,922 Asterias Biotherapeutics Inc. Series A shares in Q4 2018, an estimated $70.5K.
Group One Trading first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 14 quarters.
Group One Trading's Asterias Biotherapeutics Inc. Series A position peaked at $114K in Q3 2017.
46 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.